glp-1 agonist weight gain effects Agonists For Obesity In Non-Diabetic Patients: Game Changer Or Overhyped? A Critical Analysis GlobalRPH Part 2 of a 3-Part

Generic Ozempic is now about $100 a month across the country

Compounded Medication Disclosure: Compounded semaglutide and compounded tirzepatide are not FDA-approved finished drug products

Several limitations should be considered

Early clinical trials have shown promising results, with agents like semaglutide and exenatide demonstrating reductions in alcohol consumption and craving, as well as potential benefits for smoking cessation, such as reduced post-cessation weight gain

Key questions to discuss include: Whether you meet NHS criteria for GLP-1 prescription (type 2 diabetes or obesity with complications) The evidenceor lack thereoffor GLP-1 use specifically in Hashimoto's management Potential interactions between GLP-1 medications and thyroid hormone replacement How GLP-1 therapy might affect your thyroid function monitoring schedule Alternative evidence-based approaches to managing metabolic symptoms in Hashimoto's The costs and practicalities of private prescription if NHS funding is not available Contraception requirements if you are of childbearing potential (GLP-1 medications should be avoided in pregnancy and breastfeeding) Your GP may recommend optimising your current thyroid management first , ensuring your levothyroxine dose is appropriate and that you are not over- or under-replaced